JCT> Vol.6 No.3, March 2015

Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Thoracic Surgery, National Cancer Research Center Hospital, Tokyo, Japan
Division of Pathology, National Cancer Research Center Research Institute, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

 

Copyright © 2015 Hiroyuki Kogai, Shinji Kikuchi, Takashi Obana, Yumi Tsuboi, Tomoko Maruyama, Mika Sakurai-Yageta, Hisao Asamura, Yae Kanai, Yoshinori Murakami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Kogai, H. , Kikuchi, S. , Obana, T. , Tsuboi, Y. , Maruyama, T. , Sakurai-Yageta, M. , Asamura, H. , Kanai, Y. and Murakami, Y. (2015) Promoter Methylation of the CADM1 and 4.1B Genes Occurs Independently of the EGFR or the KRAS2 Mutation in Non-Small Cell Lung Cancer. Journal of Cancer Therapy, 6, 273-285. doi: 10.4236/jct.2015.63030.

 

Download citation as EndNote